ASMBS statements/guidelinesBariatric surgery in class I obesity (body mass index 30–35 kg/m2)
Section snippets
Preamble
The following position statement is issued by the American Society for Metabolic and Bariatric Surgery in response to numerous inquires made to the society by patients, physicians, society members, hospitals, and others regarding the safety profile and efficacy of bariatric surgery for patients with class I obesity. In this statement, available data are summarized, and recommendations for treatment are made regarding bariatric surgery for patients with a body mass index (BMI) of 30–35 kg/m2
Summary and recommendations
- 1.
Class I obesity is a well-defined disease that causes or exacerbates multiple other diseases, decreases the duration of life, and decreases the quality of life. The patient with class I obesity should be recognized as deserving treatment for this disease.
- 2.
Current options of nonsurgical treatment for class I obesity are not generally effective in achieving a substantial and durable weight reduction.
- 3.
For patients with BMI 30–35 who do not achieve substantial and durable weight and co-morbidity
References (67)
- et al.
Obesity
Lancet
(2005) Summary: Consensus conference on surgery for severe obesity
Surg Obes Relat Dis
(2005)- et al.
Initial results with sleeve gastrectomy for patients with class I obesity (BMI 30–35 kg/m2)
Surg Obes Relat Dis
(2009) - et al.
Outcomes of laparoscopic adjustable gastric banding in patients with low body mass index
Surg Obes Relat Dis
(2010) - et al.
Type 2 diabetes in obese patients with body mass index of 30–35 kg/m2: sleeve gastrectomy versus medical treatment
Surg Obes Relat Dis
(2012) - et al.
Outcomes of bariatric surgery in patients with body mass index<35 kg/m2
Surg Obes Relat Dis
(2012) - et al.
Comparative effectiveness of bariatric surgery and nonsurgical therapy in adults with type 2 diabetes mellitus and body mass index<35 kg/m2
Surgery
(2011) - et al.
Diabetes remission and reduced cardiovascular risk after gastric bypass in Asian Indians with body mass index<35 kg/m2
Surg Obes Relat Dis
(2010) - et al.
Laparoscopic adjustable gastric banding for patients with body mass index of≤35 kg/m2
Surg Obes Relat Dis
(2006) - et al.
Laparoscopic Roux-en-Y gastric bypass for BMI<35 kg/m2: a tailored approach
Surg Obes Relat Dis
(2006)
Laparoscopic sleeve gastrectomy for diabetes treatment in nonmorbidly obese patients: efficacy and change of insulin secretion
Surgery
Are bariatric surgical outcomes worth their cost? A systematic review
J Am Coll Surg
Laparoscopic adjustable gastric banding in the treatment of obesity: a systematic literature review
Surgery
Clinical outcomes of the REALIZE adjustable gastric band-C at one year in a U.S. population
Surg Obes Relat Dis
Prevalence of obesity and trends in body mass index among US children and adolescents, 1999–2010
JAMA
Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999–2010
JAMA
The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis
BMC Public Health
Bariatric surgery versus intensive medical therapy in obese patients with diabetes
N Engl J Med
Combining risk estimates from observational studies with different exposure cutpoints: a meta-analysis on body mass index and diabetes type 2
Am J Epidemiol
Asia Pacific Cohort Studies Collaboration. Body mass index and cardiovascular disease in the Asia-Pacific Region: an overview of 33 cohorts involving 310000 participants
Int J Epidemiol
Overweight as an avoidable cause of cancer in Europe
Int J Cancer
Central obesity and breast cancer risk: a systematic review
Obes Rev
Body mass index and adenocarcinomas of the esophagus or gastric cardia: a systematic review and meta-analysis
Cancer Epidemiol Biomarkers Prev
A meta-analysis of obesity and the risk of pancreatic cancer
Br J Cancer
Body size and composition and prostate cancer risk: systematic review and meta-regression analysis
Cancer Causes Control
Years of life lost due to obesity
JAMA
A potential decline in life expectancy in the United States in the 21st century
N Engl J Med
The optimal surgical management of the super-obese patient: the debate
Surg Innov
Cited by (54)
How safe is bariatric surgery in patients with class I obesity (body mass index 30–35 kg/m <sup>2</sup> )?
2019, Surgery for Obesity and Related DiseasesASMBS updated position statement on bariatric surgery in class I obesity (BMI 30–35 kg/m <sup>2</sup> )
2018, Surgery for Obesity and Related DiseasesCitation Excerpt :Since the National Institutes of Health consensus conference, new procedures have been introduced and laparoscopy has largely replaced open surgery, with higher levels of scientific evidence now available regarding the health hazards of obesity and the improved risks and benefits of bariatric surgery [46,47]. Given the major changes that have occurred in this field, it is appropriate to review the data now available, and in the context of bariatric surgery as it is currently practiced, consider modification of the arbitrary recommendations established >25 years ago [1]. Despite attempts to update the recommendations of the original guidelines [7,8], private health insurers and Medicare continue to rely on the 1991 consensus conference guidelines to set a baseline for BMI above which bariatric surgery offers a favorable risk/benefit ratio.
Esophagus-duodenum Gastric Bypass Surgery Improves Glucose and Lipid Metabolism in Mice
2018, EBioMedicineCitation Excerpt :Bariatric surgery traditionally has been recommended for severely obese patients with a body mass index (BMI) of ≥ 40 kg/m2 or for severely obese patients with BMI of ≥ 35 kg/m2 with at least 1 co-morbid condition. More recently, the indications have been expanded to include obese patients with a BMI of 30 ≥ kg/m2 and a metabolic condition, such as type 2 diabetes (Ponce et al., 2015; Brethauer, 2013). Improvement in glycemic control after bariatric surgery can be either weight loss dependent and independent.